16:45-16:55
观看视频
Anti-CD22 CAR-T cell therapy as a salvage treatment in relapsed/refractory B cell malignancy patients ineffective or relapse again after anti-CD19-CAR T therapy
16:55-17:05
观看视频
CAR-T治疗中CD19抗原表位丢失对DLBCL系统性耐药的影响及机制研究
17:05-17:15
观看视频
Predictive factors and survival influence of severe cytokine release syndrome in patients with relapsed/refractory B-ALL receiving CD19 CAR-T cell therapy
